SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : AMERICAN BIOMED, Minimally Invasive Technology (ABMI) -- Ignore unavailable to you. Want to Upgrade?


To: Dr David Summers who wrote (1460)7/14/1998 4:33:00 PM
From: greg Benfield  Respond to of 2887
 
Is there a website for that for those of us who are too lazy to go to the library?

Holding, still waiting for news...at least CLCK is going up nicely. Now, that is a company that has a good story and sends out press releases of revenue generating agreements.

Woodlands, come back Woodlands!



To: Dr David Summers who wrote (1460)7/14/1998 5:21:00 PM
From: Jeffrey L. Henken  Read Replies (1) | Respond to of 2887
 
Thanks again. That issue does not show up online yet:

mosby.com

A few years back ABMI was involved in negotiations with US Surgical. Those negotiations unfortunately failed to result in the acquisition of the company.

ABMI continues to hope to find a strategic partner or ultimately to be acquired. Acquisitions are taking place in this industry at an incredible rate.

I think ABMI continues to make progress in 1998. Obviously it's not happening as rapidly as shareholders would like but it continues to happen nonetheless.

Don't you think that ABMI has something of value to another company in 1998?

I mean mantle7 would like us to believe that just because ABMI is not reinventing the wheel that there is no market for any of their products either currently being sold or in R&D. I find that hard to believe.

Lets look at the example of the many company's developing technology for AAA or transluminal grafting. AVEI paid $62 million dollars for World Medical, a company who apparently is far from the only potential player in in this field. The earliest this technology will reach the US market is late in the year 2000.

I guess what I am saying is there is a market for ABMI's products. How successful ABMI can be at marketing them is the big question. Obviously American BioMed could use some help in this area either from the aspect of a strategic partner or as an acquisition candidate. Still progress is being made in my opinion. I am looking to buy more ABMI soon because the stock is oversold.

This is just a rotten time in the market for small cap and microcap stocks. Ultimately it's a great time to buy stocks in this area, although no one can say for certain when they will turn higher again. Personally I hope it is soon.

Regards, Jeff